Different Responses of Aripiprazole Combination Treatment in Antipsychotics-Induced Hyperprolactinemia: 2 Cases.
- Author:
Jin Woo CHO
1
;
Seung Min OH
;
Chul Eung KIM
Author Information
1. Department of Psychiatry, Inha University School of Medicine, Inha University Hospital, Incheon, Korea. kce320@inha.ac.kr
- Publication Type:Case Report
- Keywords:
Aripiprazole combination therapy;
Hyperprolactinemia;
Olanzapine;
Amisulpride
- MeSH:
Hyperprolactinemia*
- From:Korean Journal of Psychopharmacology
2015;26(2):58-60
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Hyperprolactinemia is a well-known neuroendocrine side effect to antipsychotic agent. Combined treatment of aripiprazole is recognized as an effective solution against hyperprolactinemia caused by antipsychotic agent. We report 2 progressive clinical cases where both are treated with combined use of aripiprazole which has a unique mechanism of action to resolve olanzapine and amisulpride-induced hyperprolactinemia.
